The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus

Infectious Diseases in Clinical Practice

Volumn 6, Issue 7, 1997, Pages 449-454

  Classen, David C ^b   Classen, John Barthelow ^a  

^a Classen Immunotherapies Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; SMALLPOX VACCINE;

ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNIZATION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; RISK; TIME; VACCINATION; WESTERN EUROPE;

EID: 0030690171     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199706070-00007     Document Type: Article

References (36)

1. Maclaren N. Immunology of diabetes mellitus. Ann Allergy 1992;68:5-9
2. Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996;24: 137-45.
3. Green A, Gale EAM, Patterson CC. Incidence of childhood-onset insulin-dependent diabetes mellitus. the EURODIAB ACE study. Lancet 1992;339:905-9.
4. Nystrom L, Dahlquist G. Rewers M, Wall S. The Swedish childhood diabetes study. An analysis of the temporal variation in diabetes incidence 1978-1987. Int J Epidemiol 1990;19-141-6
5. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, et al. Epidemiology of childhood diabetes mellitus in Finland: back-ground of a nationwide study of type I (insulin-dependent) diabetes mellitus. Diabetologia 1992;35:70-6.
6. Tuomilehto J, Virtala E, Karvonen M, et al. Increase in incidence of insulin-dependent diabetes mellitus among children in Finland Int J Epidemiol 1995;24:984-92.
7. Scott R, Brown LJ, Darlow BA, Forbes LV, Moore MP. Temporal variation in incidence of IDDM in Canterbury, New Zealand. Diabetes Care 1992,15:895-9.
8. Schranz AG, Prikatsky V. Type I diabetes in the Maltese islands Diabet Med 1989.6:228-31
9. Metcalfe MA, Baum JD Incidence of insulin dependent diabetes in children aged under 15 years in the British Isles during 1988. BMJ 1991;302:443-7.
10. RIOS MS, Moy CS, Serrano RM. et al. Incidence of type I (insulin-dependent) diabetes mellitus in subjects 0-14 years of age in the Comuniad of Madrid, Spain. Diabetologia 1990;33:422-4.
11. Schoenle EJ, Molinari L, Bagot M, Semadeni S, Wiesendanger M. Epidemiology of IDDM in Switzerland. Diabetes Care 1994;17:955-60.
12. Helgason T, Danielsen T, Thorsson AV. Incidence and prevalence of type I (insulin-dependent) diabetes mellitus in Icelandic children 1970-1989. Diabetologia 1992; 35.880-3.
13. Bytchenko B. Immunization calendars in developed countries. WHO: Regional Office for Europe; 1990
14. Lafontaine A. Vaccination programmes in Belgium. Symposium Series Immunobiol Standard 1973;22:223-5.
15. Romanus V, Jonsell R, Berquist S. Pertussis in Sweden after cessation of general immunization in 1979. Pediatr Infect Dis J 1987;6:364-71
16. Sievers CJ. The Danish immunization programme. Symposium Series Immunobiol Standard 1973;22:235-7.
17. Binkin NJ, Salmaso S, Tozzi AE, Scuderi G, Greco D Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience. Pediatr Infect Dis J 1992;11:653-61.
18. Eskola J, Kayhty H, Takala AK, et al. A randomized, prospective field trial of a conjugated vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 1990;323:1381-7.
19. Tverdal A, Funnemark E. Protective effect of BCG vaccination in Norway 1956-1973. Tubercle, London 1988;69: 119-23.
20. Dahlquist G, Mustonen L Childhood onset diabetes-time trends and climatological factors. Int J Epidemiol 1994; 23.1234-41.
21. Dahlquist G, Gothefors L The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 1995;38:873-4.
22. Lundbeck H. Vaccination programmes in Sweden. Symp Series Immunobiol Standard 1973;22:279-86.
23. Peltola H, Makela PH, Kayhty H, et al. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to 5 years of age. N Engl J Med 1977; 297 686-91.
24. Houvila R, Kuronen T, Jannes L, Hallman N. Agglutinins in children vaccinated with the DPT vaccine used in Finland, serotypes of Bordetella pertussis strains isolated during whooping cough epidemics in 1976-1977 and whooping cough attack rate in children in epidemic areas. Acta Paediatr Scand Suppl 1982;298-21-5.
25. Hyoty H, Hiltunen M, Reunanen A, et al. Decline of mumps antibodies in type I (insulin-dependent) diabetic children and a plateau in the rising incidence of type I diabetes after introduction of the mumps-measles-rubella vaccine in Finland Diabetologia 1993;36.1303-8.
26. Eskola J, Kayhty H, Takala AK, et al. A randomized, prospective field trial of a conjugated vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 1990;323:1381-7
27. Akerblom HK, Reunanen A. The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and northern Europe. Diabetes Care 1985:8 (4 Suppl): 10-6.
28. Classen JB. Diabetes epidemic follows hepatitis B immunization program. N Z Med J 1996;109:195.
29. Dahlquist G, Frisk G, Svanberg L, Forsgren L, Didherolom H. Indications that maternal Coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995;38:1371-3.
30. Patterson CC, Carson DJ, Hadden DR. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with the highest population density and most household crowding. Diabetologia 1996;39: 1063-9.
31. Virtanen SM, Rasanen L, Ylonen K, et al. Early introduction of dairy products associated with increased risk of IDDM in Finnish children. Diabetes 1993;42:1786-90.
32. Rewers M. Geographic patterns of childhood insulin dependent diabetes mellitus Diabetes 1988;37:1113-9.
33. Cucca F, Muntoni F, Lampis R, et al. Combinations of Specific DRB1, DQA1, DQB1, haplotypes are associated with insulin dependent diabetes mellitus in Sardinia Hum Immunol 1993;37:85-94.
34. Dahlquist G, Kallen B. Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type I (insulin-dependent) diabetes mellitus. Diabetologia 1992;35.671-5.
35. Huang X, Yuan J, Goddard A, et al. Interferon expression in pancreases of patients with type I diabetes. Diabetes 1995,44:658-64.
36. Stanley SK, Ostrowski MA. Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunode-ficiency virus type 1. N Engl J Med 1996;334 1222-30.